HFT

HYDROXYFLUTAMIDE

Find entries where: HFT

is present as a standalone ligand in 8 entries

Find related ligands:

Chemical Component Summary
Name	HYDROXYFLUTAMIDE
Synonyms	2-HYDROXY-2-METHYL-N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE; HYDROXYNIPHTHOLIDE
Identifiers	2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
Formula	C₁₁ H₁₁ F₃ N₂ O₄
Molecular Weight	292.211
Type	NON-POLYMER
Isomeric SMILES	CC(C)(C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-])O
InChI	InChI=1S/C11H11F3N2O4/c1-10(2,18)9(17)15-6-3-4-8(16(19)20)7(5-6)11(12,13)14/h3-5,18H,1-2H3,(H,15,17)
InChIKey	YPQLFJODEKMJEF-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	31
Chiral Atom Count	0
Bond Count	31
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB00499
Name	Flutamide
Groups	approved investigational
Description	An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Synonyms	Flutamide Niftolid 4'-nitro-3'-trifluoromethylisobutyranilide α,α,α-trifluoro-2-methyl-4'-nitro-m-propionotoluidide Flutamida FTA NFBA Flutamid Flutamidum Niftolide
Brand Names	Penta-flutamide Nu-flutamide Tablets Eulexin Teva-flutamide Dom-flutamide Flutamide PMS-flutamide Euflex Flutamide-250
Indication	For the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate
Categories	Amides Amines Androgen Receptor Antagonists Androgen Receptor Inhibitors Anilides Aniline Compounds Antiandrogens Antiandrogens, non-steroidal Antineoplastic Agents Antineoplastic Agents, Hormonal Antineoplastic and Immunomodulating Agents Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Endocrine Therapy Hormone Antagonists Hormone Antagonists and Related Agents Hormones, Hormone Substitutes, and Hormone Antagonists Methemoglobinemia Associated Agents
ATC-Code	L02BB01
CAS number	13311-84-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Androgen receptor	MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPP...	unknown	antagonist
Aryl hydrocarbon receptor	MNSSSANITYASRKRRKPVQKTVKPIPAEGIKSNPSKRHRDRLNTELDRL...	unknown	agonist
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	substrate
Cytochrome P450 1B1	MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSA...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Multidrug resistance-associated protein 1	MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACF...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682